- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04671082
Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm (RESUME-1)
March 21, 2022 updated by: Neurana Pharmaceuticals, Inc.
A Phase 3, 14-Day, Double-blind, Randomized, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
This is a double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of tolperisone (a non-opioid) or placebo administered in subjects with pain due to acute back muscle spasm.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1004
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Surprise, Arizona, United States, 85374
- Clinical Research Institute of Arizona, LLC
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72212
- Applied Research Center of Arkansas
-
-
California
-
Canoga Park, California, United States, 91304
- Alliance Research Institute
-
Long Beach, California, United States, 90806
- Long Beach Clinical Trials Services, Inc
-
Sacramento, California, United States, 95821
- Northern California Research
-
Torrance, California, United States, 90502
- Collaborative Neuroscience Research, LLC
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Lynn Institute of Denver
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20011
- Emerson Clinical Research Institute
-
-
Florida
-
Lake City, Florida, United States, 32055
- Multi-Specialty Research Associates, Inc.
-
Miami, Florida, United States, 33126
- LCC Medical Research Institute, LLC
-
Miami Lakes, Florida, United States, 33014
- Savin Medical Group
-
Orange City, Florida, United States, 32763
- Accel Research Sites
-
Orlando, Florida, United States, 32807
- Combined Research Orlando
-
-
Georgia
-
Decatur, Georgia, United States, 30030
- iResearch Atlanta
-
Lawrenceville, Georgia, United States, 30044
- Georgia Clinical Research LLC
-
-
Illinois
-
Chicago, Illinois, United States, 60602
- IMA Clinical Research, PC
-
Evanston, Illinois, United States, 60201
- Evanston Premier Healthcare Research LLC
-
-
Indiana
-
Brownsburg, Indiana, United States, 46112
- Investigators Research Group
-
-
Kansas
-
Wichita, Kansas, United States, 67205
- Professional Research Network of Kansas, LLC
-
-
Kentucky
-
Owensboro, Kentucky, United States, 42303
- Research Integrity, LLC
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70124
- DelRicht Research
-
Prairieville, Louisiana, United States, 70769
- DelRicht Research
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48104
- Michigan Head Pain and Neurological Institute
-
Rochester Hills, Michigan, United States, 48307
- Onyx Clinical Research
-
-
Mississippi
-
Ridgeland, Mississippi, United States, 39157
- Quinn Healthcare/SKYCRNG
-
-
Missouri
-
Saint Louis, Missouri, United States, 63117
- IMA Clinical Research
-
-
Nebraska
-
Bellevue, Nebraska, United States, 68005
- Pioneer Clinical Research, LLC
-
Elkhorn, Nebraska, United States, 68022
- Skyline Medical Center, PC
-
-
Nevada
-
Las Vegas, Nevada, United States, 89106
- Jubilee Clinical Research, Inc.
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87102
- Albuquerque Clinical Trials, Inc.
-
-
New York
-
Brooklyn, New York, United States, 11229
- Integrative Clinical Trials, LLC
-
Hartsdale, New York, United States, 10530
- Drug Trials America
-
New York, New York, United States, 10036
- Manhattan Behavioral Medicine PLLC
-
Staten Island, New York, United States, 10302
- Advanced Research Solutions, LLC
-
Williamsville, New York, United States, 14221
- Upstate ClinicalResearch Associates LLC
-
-
North Carolina
-
Shelby, North Carolina, United States, 28150
- Carolina Research Center, Inc.
-
Winston-Salem, North Carolina, United States, 27103
- Progressive Medicine of the Triad, LLC
-
-
Ohio
-
Cincinnati, Ohio, United States, 45215
- Hometown Urgent Care and Research
-
Columbus, Ohio, United States, 43214
- Hometown Urgent Care and Research
-
Dayton, Ohio, United States, 45424
- Hometown Urgent Care and Research
-
Youngstown, Ohio, United States, 44505
- Onyx Clinical Research
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73129
- Today Clinical Research
-
Tulsa, Oklahoma, United States, 74133
- DelRicht Research
-
-
Pennsylvania
-
Smithfield, Pennsylvania, United States, 15478
- Frontier Clinical Research, LLC
-
-
South Carolina
-
Anderson, South Carolina, United States, 29651
- PCPMG Clinical Research Unit, LLC
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37909
- New Phase Research & Development, LLC
-
-
Texas
-
Austin, Texas, United States, 78705
- Central Texas Clinical Research
-
Austin, Texas, United States, 78735
- Premier Family Physicians
-
Carrollton, Texas, United States, 75007
- ClinRX Research Joseph INC
-
Houston, Texas, United States, 77058
- Centex Studies, Inc.
-
Houston, Texas, United States, 77090
- Centex Studies, Inc.
-
Katy, Texas, United States, 77494
- R & H Clinical Research
-
Plano, Texas, United States, 75024
- Village Health Partners
-
San Antonio, Texas, United States, 78215
- Sun Research Institute
-
-
Virginia
-
Danville, Virginia, United States, 24541
- Spectrum Medical, Inc.
-
Newport News, Virginia, United States, 23606
- Health Research of Hampton Roads, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ambulatory
- Current acute back pain due to acute muscle spasm starting within 7 days prior to study entry (Day 1) and at least 8 weeks following resolution of the last episode of acute back pain.
- Willingness to discontinue all previous or ongoing treatment of pain or muscle spasm on study entry at Day 1 through the end of treatment including medication, acupuncture, chiropractic adjustment, massage, transcutaneous electrical nerve stimulation [TENS], or physiotherapy.
- Pain must be localized from the neck (C-3 or lower) to the inferior gluteal folds and spasm assessed during the Screening physical examination.
- Body mass index range between 18 and 35 kg/m², inclusive.
Exclusion Criteria:
- Presence of acute or chronic back pain for the previous 8 days or longer, where back pain is present on more days than not.
- Presence of neurogenic pain in the back, neck, upper or lower extremities, including pain from (or suspected from) nerve root compression or injury (radicular pain or "pinched nerve") or neuropathic pain. Evidence of these types of exclusionary pain includes radiation of pain that radiates beyond the back, chronic pain, and pain associated with abnormal sensation or loss of sensation in the back or extremities.
- Presence of pain anywhere other than the target back pain that is bothersome, interferes with activity, or for which pain relief is taken.
- History of any neck, back, or pelvic surgery.
- History within the previous 3 years of: spinal fracture or spinal infection; inflammatory arthritis; degenerative spine disease; or any other back or spine condition that may reasonably contribute to current back pain.
- Subjects who test positive for alcohol by breathalyzer test or have a positive urine drug screen for drugs of abuse (e.g. amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, cannabinoids, oxycodone, opiates), including cannabis even where legal, at Screening.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
TID
|
Experimental: Tolperisone 50 mg
|
TID
Other Names:
|
Experimental: Tolpersione 100 mg
Tolperisone 100 mg
|
TID
Other Names:
|
Experimental: Tolperisone 200 mg
|
TID
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numerical rating scale (NRS)
Time Frame: Day 1 to Day 14
|
Numerical rating scale (NRS), a 0-10 scale, from no pain to worst possible pain - Subject-rated pain "right now" due to acute back spasm.
|
Day 1 to Day 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2020
Primary Completion (Actual)
December 13, 2021
Study Completion (Actual)
March 21, 2022
Study Registration Dates
First Submitted
December 10, 2020
First Submitted That Met QC Criteria
December 15, 2020
First Posted (Actual)
December 17, 2020
Study Record Updates
Last Update Posted (Actual)
March 22, 2022
Last Update Submitted That Met QC Criteria
March 21, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Dyskinesias
- Acute Pain
- Hyperkinesis
- Spasm
- Muscle Cramp
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Neuromuscular Agents
- Muscle Relaxants, Central
- Tolperisone
Other Study ID Numbers
- CLN-301
- RESUME-1 (Other Identifier: Neurana Pharmaceuticals)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Marco LoggiaNational Institute of Neurological Disorders and Stroke (NINDS)Active, not recruitingLow Back Pain | Pain, Chronic | Back Pain Lower Back Chronic | Back Pain With Radiation | Back Pain Without Radiation | Back AcheUnited States
-
Carilion ClinicVirginia Center for Health InnovationEnrolling by invitationBack Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Dan RhonNational Center for Complementary and Integrative Health (NCCIH); 59th Medical... and other collaboratorsRecruitingLow Back Pain | Chronic Pain | Surgery | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Balgrist University HospitalUniversity of Zurich, Epidemiology, Biostatistics and Prevention InstituteCompletedBack Pain | Back Pain With Radiation | Back Pain, LowSwitzerland
-
Vanderbilt University Medical CenterWithdrawnBack Pain, Low | Back Pain Without RadiationUnited States
-
Columbia UniversityUpright Technologies Ltd.CompletedLower Back Pain | Back Pain | Postural Low Back PainUnited States
Clinical Trials on Tolperisone Hydrochloride
-
Neurana Pharmaceuticals, Inc.Completed
-
Semmelweis UniversityNational Research Develpment and Innovation Fund, Hungary; MEDITOP Pharmaceutical...Recruiting
-
AvigenTerminatedMuscle SpasticityCzech Republic, Ukraine, Germany, Russian Federation, Serbia
-
AvigenTerminatedMuscle SpasticityUnited States, Canada
-
Neurana Pharmaceuticals, Inc.Cognitive Research CorporationCompleted
-
Neurana Pharmaceuticals, Inc.Completed
-
Neurana Pharmaceuticals, Inc.CompletedBack Pain | Low Back Pain | Acute Pain | Muscle Cramp | Back Strain | Muscle Spasm | Back Spasm Upper BackUnited States
-
Xijing Hospital of Digestive DiseasesCompleted
-
Xijing Hospital of Digestive DiseasesCompletedColorectal AdenomasChina
-
Shenyang Sunshine Pharmaceutical Co., LTD.UnknownUremic PruritusChina